XML 54 R41.htm IDEA: XBRL DOCUMENT v3.26.1
Equity Incentive Plans (Tables)
 12 Months Ended
Jan. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Recognized Stock-based Compensation Expense
The Company recognized stock-based compensation expense related to its equity incentive plans as follows (in thousands):
Year Ended January 31,
202420252026
Cost of revenue:
Subscription
$2,810$3,190$3,305
Professional services and other
1,7351,2231,190
Sales and marketing
25,01519,99514,250
Research and development
19,52018,24516,822
General and administrative
14,56515,89220,270
Other expense, net
703821218 
Total
$64,348 $59,366 $56,055 
Schedule of Outstanding Stock Options and Related Activity
The following table sets forth the outstanding common stock options and related activity for the years ended January 31, 2024, 2025 and 2026:
Shares
Subject to Outstanding Options		Weighted- Average Exercise
Price per Share		Weighted-Average Remaining Contractual Term (years)Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2023876,284 $26.40 1.9$59 
Exercised(7,638)8.40 
Expired(75,332)26.95 
Outstanding as of January 31, 2024793,31426.521.0$—
Exercised— — 
Expired(722,461)25.59 
Outstanding as of January 31, 202570,85336.06 1.7$—
Exercised— — 
Expired(35,568)44.37
Outstanding as of January 31, 202635,285$27.680.7$—
Schedule of Outstanding RSUs and Related Activity
The details of this award are summarized as follows:
Minimum Time Vest
Number of Shares
Stock Price Hurdle
Grant Date Fair Value
Requisite Service (in years)
Tranche 1
One-year anniversary of grant date
150,000$20.00 $13.13 1.00
Tranche 2
One-year anniversary of grant date
150,00025.00 12.31 1.00
Tranche 3
One-year anniversary of grant date
75,000 35.00 10.90 1.47
Tranche 4
One-year anniversary of grant date
75,000 45.00 9.73 1.97
The following table sets forth the outstanding RSUs and related activity for the years ended January 31, 2024, 2025 and 2026:
Number of Shares Weighted- Average Grant Date Fair Value
Outstanding as of January 31, 20233,894,094 $48.27 
Granted3,523,844 14.38 
Vested(1,742,989)46.69 
Canceled(948,659)38.85 
Outstanding as of January 31, 20244,726,290 25.61 
Granted3,367,104 7.96 
Vested(2,378,046)27.46 
Canceled(645,187)26.56 
Outstanding as of January 31, 20255,070,16113.91 
Granted4,343,17611.35 
Vested(3,041,911)15.56 
Canceled(328,997)14.07 
Outstanding as of January 31, 20266,042,429$11.22 
Schedule of Weighted-average Assumptions Used in Determining Grant-date Fair Value of ESPP Purchase Rights
The fair value of the purchase rights for the ESPP are estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:
Year Ended January 31,
202420252026
Expected stock price volatility
74% - 93%
45% - 65%
51% - 80%
Expected term
0.5 - 1.0 year
0.5 - 1.0 year
0.5 - 1.0 year
Risk-free interest rate
4.60% - 5.58%
3.96% - 5.36%
3.62% - 4.23%
Expected dividend yield–––